2021 World Orphan Drug Congress
About the Event:
Gaylord National Harbor Hotel, Oxon Hill, Maryland
August 25-27, 2021
We will be on the ground live to talk about how we are harnessing the power of physicians, scientists, commercial strategists and key professionals to ensure a holistic view to shorten the distance from lab to life for rare disease therapies and patients waiting for them.
Visit us at booth #15 to meet with members of our Clinical, Decentralized Solutions, Real World Late Phase, Rare Disease, Syneos One, Illingworth and Synteract teams and learn more about our integrated, patient-centered product development and commercialization approach for rare disease.
Don’t miss your chance to win a copy of our new book publishing in September:
Rare Disease Drug Development: Clinical, Scientific, Patient and Caregiver Perspectives.
Simply go to the Syneos Health booth at the World Orphan Drug Conference and enter your name to win!
Featuring contributions from Syneos Health experts across the clinical-commercial spectrum, this book offers unique insights from various perspectives, including third-party capital providers, caregivers, patient advocacy groups, drug development professionals, marketing and commercial experts, and patients.
Featured Sessions:
Critical Considerations for Successful Conduct of Decentralized Clinical Trials for Rare Diseases
August 26, 2021 | 11:15-11:35am EST
Russell Griffith, DCT Manager
Feasibility First: Establishing Effective Recruitment Strategies for Rare Oncology Clinical Trials
August 26, 2021 | 3:35-3:55pm EST
Jess Conicelli, Executive Director, Strategic Development, Rare, Orphan, & Pediatric Diseases, Synteract
Syneos Health Additional Resources:
- Rare Disease Day Symposium 2021: Harnessing the Power Of Community
- Rare Disease Drug Development: Innovation Perspectives
- Rare Disease Day Video
- Fireside Chat on Rare Diseases: Listening to Patients and Advocacy Groups
- Challenges and Opportunities in Epilepsy Clinical Trials
- Innovation perspectives in Rare Disease Drug Development
Synteract Additional Resources:
- Gene Therapy for Cystic Fibrosis: Advancing the Promise of Future Treatment
- Operationalizing Recruitment & Retention in Rare Disease Trials
- Rare Cancers: What to Consider for Complex Clinical Studies
